Bardin Hill Management Partners’s SpringWorks Therapeutics SWTX Stock Holding History

Bardin Hill Management Partners’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-84,000	Closed	-$3.71M	–	56
2025 Q1	$3.71M	Buy	+84,000	New	+$3.87M	1.21%	25

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bardin Hill Management Partners's SWTX Position: Q3 2025 in Review

Bardin Hill Management Partners sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 89,853 shares — an estimated $4.22M sold.

Bardin Hill Management Partners first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $4.22M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Bardin Hill Management Partners reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Bardin Hill Management Partners sold 89,853 SpringWorks Therapeutics shares in Q3 2025, an estimated $4.22M.
Bardin Hill Management Partners first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Bardin Hill Management Partners's SpringWorks Therapeutics position peaked at $4.22M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Bardin Hill Management Partners's 13F filing for Q3 2025, filed 12 Nov 2025.